GlassScriptPhysician profile
Adam J Mariotti
NPI 1184884298
$4,580.83
in general payments reported to CMS, 2019-2025
35 companies · $757 in 2025
The $757 reported for 2025 was more than what 75% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $243 · 2021: $409 · 2022: $494 · 2023: $494 · 2024: $1,669 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,860 · Consulting Fee: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.92 |
| Consulting Fee | $1,060.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,432.47 | 2021-2025 | |
| Glaxosmithkline, LLC. | $611.63 | 2019-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $405.44 | 2019-2025 | Dupixent, Libtayo |
| Stryker Corporation | $399.73 | 2019-2025 | Xpress Loprofile |
| Optinose US, INC. | $248.98 | 2019-2025 | |
| Aerin Medical INC. | $156.26 | 2020-2025 | |
| Genentech USA, INC. | $151.39 | 2019-2025 | Xolair |
| Novartis Pharmaceuticals Corporation | $133.01 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $114.24 | 2025 | Neffy |
| Jazz Pharmaceuticals INC. | $92.62 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $91.38 | 2019-2025 | Fasenra, Tezspire |
| Sanofi-Aventis U.S. LLC | $74.75 | 2022 | |
| Neurent Medical Limited | $65.99 | 2022 | |
| Acclarent, INC | $57.84 | 2022-2023 | Trudi Nav Cable |
| Harmony Biosciences LLC | $56.90 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $49.72 | 2023-2024 | Auvi-Q |
| Alk-Abello, INC | $47.35 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $47.19 | 2025 | |
| Smith+Nephew, INC. | $34.45 | 2023 | Rapid Rhino, Tula |
| Intersect Ent, INC. | $33.91 | 2020-2021 | |
| Axsome Therapeutics, INC. | $27.96 | 2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $24.60 | 2020 | |
| Lilly USA, LLC | $23.47 | 2025 | Zepbound |
| Eisai INC. | $23.32 | 2021 | |
| Integra Lifesciences Corporation | $23.10 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Pfizer INC. | $20.82 | 2023 | |
| Resmed Corp | $20.42 | 2024 | |
| Inspire Medical Systems, INC. | $19.80 | 2023 | Inspire |
| Phadia US INC. | $19.02 | 2025 | Immunocap |
| Medtronic, INC. | $15.80 | 2025 | Propel |
| Aimmune Therapeutics, INC. | $13.50 | 2021 | |
| Olympus America INC. | $11.41 | 2020 | |
| Medtronic USA, INC. | $10.97 | 2019 | |
| Cook Medical LLC | $10.90 | 2019 | |
| Fortovia Therapeutics, INC. | $10.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Mariotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.